We found 574 records for "Regulatory / compliance"

Articles

Privacy in clinical genomics: the risk of missing the point

16th March 2015

 Privacy in clinical genomics: the risk of missing the pointArticles

As the European Commission considers ramping up data security, with the introduction of the EU Data Protection Regulation (EUDPR), Jurgi Camblong cautions that extending existing rules runs the risk of...

Read more

PR to pharma: up your dosage of social media

13th March 2015

 PR to pharma: up your dosage of social mediaArticles

Many pharma companies remain concerned about running afoul of the regulators with their online activities and therefore have not yet fully embraced new channels. However, increasingly patients want and expect...

Read more

Protecting the future: the regenerative medicine evolution

10th March 2015

 Protecting the future: the regenerative medicine evolutionArticles

Regenerative medicine has left the realms of sci-fi to become a practical, new form of technology, which can give patients amazing results with serious, previously untreatable injuries. However, the legalities...

Read more

Stay or go? The UK’s PPRS and the statutory scheme for pricing branded medicines

9th March 2015

 Stay or go? The UK’s PPRS and the statutory scheme for pricing branded medicinesArticles

The latest Pharmaceutical Price Regulation Scheme (PPRS) is barely into its second year of operation but with rising payments to the Department of Health (DH) confirmed at the end of...

Read more

News

Deal agreed at last on GSK's Bexsero in UK

30th March 2015

 Deal agreed at last on GSK's Bexsero in UKNews

After months of delay, GlaxoSmithKline has agreed a deal with the UK government that will allow its meningitis B (MenB) vaccine Bexsero to be added to the NHS' routine childhood...

Read more

Novartis drug gets 'Promising Innovative Medicine' status in UK

30th March 2015

 Novartis drug gets 'Promising Innovative Medicine' status in UKNews

Novartis's cancer drug Zykadia has become one of the first drugs to snag Promising Innovation Medicine status in the UK's new early access scheme.The Early Access to Medicines Scheme (EAMS)...

Read more

Keytruda beats Yervoy in first-line melanoma

25th March 2015

 Keytruda beats Yervoy in first-line melanomaNews

Merck's cancer immunotherapy drug Keytruda has shown it can extend overall survival and progression free survival in advanced melanoma patients compared to Bristol-Myers Squibb's (BMS) Yervoy.The news is significant, as...

Read more

NICE says no to Celgene myeloma drug Imnovid

25th March 2015

 NICE says no to Celgene myeloma drug ImnovidNews

NICE has issued final guidance not recommending Celgene's multiple myeloma treatment Imnovid (pomalidomide).Imnovid was approved in August 2013 for treating patients with multiple myeloma in combination with dexamethasone after two...

Read more

White Papers

"The future ain’t what it used to be"

25th November 2014

 "The future ain’t what it used to be"White Papers

Preparation is key to creating and maintaining a strong drugs pipeline. However, the statistics demonstrate that successful product commercialisation strategies are not always implemented. Products are developed for which there...

Read more

Healthcare Innovation: the big ideas shaping the future of pharma

17th November 2014

 Healthcare Innovation: the big ideas shaping the future of pharmaWhite Papers

The transformation taking place in healthcare is challenging for everyone and adaptability is key for the pharma industry's continued success.Long production cycles, concentration on specialist drugs with high price tags,...

Read more

How pharma Tweetchats can drive healthcare innovation

29th April 2014

 How pharma Tweetchats can drive healthcare innovationWhite Papers

During the course of 2013 Boehringer Ingelheim explored the use of multi-way communication on Twitter, via Tweetchats, as a means to better understand disease area issues and directly connect with...

Read more

Who are the pharma social media butterflies?

19th March 2014

 Who are the pharma social media butterflies?White Papers

Social media has got everyone talking and it seems like everyone in pharma is talking about social media, so Ogilvy Healthworld figured it was time to analyse who were the...

Read more

Audio & Video

Live webinar/debate - Feb 4th - COPD, connecting real world needs to patient centric solutions

    COPD is a widespread, costly and largely preventable condition which affects over 300 million people worldwide and is recognised as the ‘third-leading’ cause of death in most countries. Adherence rates...

Read more

On demand webinar: The Price is Right? - Delivering UK access for niche patient populations

  With challenges to highly priced rare disease medicines and the Cancer Drug Fund evolving again – what is next, what are the ramifications for high priced/innovative treatments delivering beneficial outcomes...

Read more

Events

The 2nd IP Counsel Exchange on Post-Grant Patent Challenges at the PTAB

30th March 2015 - 31st March 2015

The 2nd IP Counsel Exchange on Post-Grant Patent Challenges at the PTAB

*The first in-house/corporate counsel attend for free* Join your in-house peers at the Post-Grant Patent Challenges at the PTAB on March 30-31 at San Jose City Hall, the future home...

Read more

6th Annual Medical Device and Diagnostic Sales Training and Development Conference

30th March 2015 - 31st March 2015

6th Annual Medical Device and Diagnostic Sales Training and Development Conference

Assess the future of sales training through cost effectively leveraging mobile technologies while strategically approaching customers in a dynamic health environment and recruiting sales champion while uncovering the psychology behind...

Read more

5th Annual Medical Device Clinical Training and Education Conference

30th March 2015 - 31st March 2015

5th Annual Medical Device Clinical Training and Education Conference

Evaluate clinical training techniques to maximize the healthcare professionals focus, comprehension and retention of information, developing course materials and content for global dissemination, and quantifying the effectiveness of clinical training...

Read more

Regulatory Affairs in Biosimilars

31st March 2015

Regulatory Affairs in Biosimilars

Globally there are 280 biosimilars in the pipeline and their clinical trials are increasing at a rate of 20% annually. Significant factors that are responsible for the growth of the...

Read more

Press Releases

Veeva Systems Introduces Veeva OpenKey

24th March 2015

Veeva Systems Introduces Veeva OpenKey

  Veeva Systems has launched Veeva OpenKey, a new type of customer data solution for the life sciences industry.  As the life sciences business continues to diversify across borders and new channels,...

Read more

Adelphi Research UK Refreshes Corporate Brand & Positioning

4th March 2015

Adelphi Research UK Refreshes Corporate Brand & Positioning

    Adelphi Research UK has a strong heritage of providing robust market research in the healthcare sector. Established since 2000, they have extensive expertise in pharma, and also span OTC and...

Read more

OPEN Health introduces its market access division OPEN Access Consulting

8th December 2014

OPEN Health introduces its market access division OPEN Access Consulting

Marlow, 4 December 2014: OPEN Health announced the launch of its dedicated market access division, OPEN Access Consulting. OPEN Access Consulting brings together existing market access expertise from Succinct Medical Communications...

Read more

3 TIPS FOR PATIENT ENGAGEMENT; DEFINE, ACT THEN ACCELERATE

23rd September 2014

3 TIPS FOR PATIENT ENGAGEMENT; DEFINE, ACT THEN ACCELERATE

Forbes blogger Leonard Kish described “patient engagement as the blockbuster drug of the century” namely for its potential impact on improving patient outcomes. Two years on from his article, I asked;...

Read more